David E Liddle's Net Worth
Estimate Recalculated Dec 3, 2025 08:11PM EST
Who is David E Liddle
David E Liddle does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include LEADIS TECHNOLOGY INC, OCCAM NETWORKS INC/DE, Altus Pharmaceuticals Inc., NEW YORK TIMES CO, IMPERVA INC, Guidewire Software, Inc., Inspire Medical Systems, Inc., Intersect ENT, Inc., AtriCure, Inc., MAXLINEAR INC, BOX INC, OncoMed Pharmaceuticals Inc, INPHI Corp, INTERMOLECULAR INC, and @ROAD, INC.
SEC CIK
David E Liddle's CIK is 0001212726
Past Insider Trading and Trends
2010 was David E Liddle's most active year for acquiring shares with 3 total transactions. David E Liddle's most active month to acquire stocks was the month of March. 2013 was David E Liddle's most active year for disposing of shares, totalling 2 transactions. David E Liddle's most active month to dispose stocks was the month of March. 2018 saw David E Liddle paying a total of $174,998.88 for 5,144 shares, this is the most they've acquired in one year. In 2013 David E Liddle cashed out on 4,283 shares for a total of $49,674.40, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
